SUNNYVALE, Calif., July 8 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced that it will report financial results for its
second quarter ended June 30, 2010,
on Thursday, July 22, 2010, after the
close of the market.
The company will host a management presentation at 2 p.m. Pacific Time on Thursday, July 22, 2010, to discuss the results.
To access the live webcast, please visit Cepheid's website at
www.cepheid.com/investors at least 15 minutes before the scheduled
start time to download any necessary audio or plug-in software.
A replay of the webcast will be available shortly following
the call and will remain available for at least 90 days.
Interested participants and investors may also listen to the
live teleconference call by dialing (866) 761-0748 (domestic) or
(617) 614-2706 (international), and entering participant code
64453418. A replay will be available for seven days beginning
at 4 p.m. Pacific Time. Access
numbers for this replay are (888) 286-8010 (domestic) and (617)
801-6888 (international), with participant code 17778236.
About Cepheid
Based in Sunnyvale, Calif.,
Cepheid (Nasdaq: CPHD) is an on-demand molecular diagnostics
company that develops, manufactures, and markets fully-integrated
systems and tests for genetic analysis in the clinical, industrial
and biothreat markets. The company's systems enable rapid,
sophisticated genetic testing for organisms and genetic-based
diseases by automating otherwise complex manual laboratory
procedures. The company's easy-to-use systems integrate a
number of complicated and time-intensive steps, including sample
preparation, DNA amplification and detection, which enable the
analysis of complex biological samples in its proprietary test
cartridges. Through its strong molecular biology
capabilities, the company is focusing on those applications where
rapid molecular testing is particularly important, such as
identifying infectious disease and cancer in the clinical market;
food, agricultural, and environmental testing in the industrial
market; and identifying bio-terrorism agents in the biothreat
market. See http://www.cepheid.com for more information.
CONTACTS:
|
|
|
For Media Inquiries:
|
For Investor Inquiries:
|
|
Jared Tipton
Cepheid Corporate
Communications
Tel: (408) 400 8377
jared.tipton@cepheid.com
|
Jacquie Ross
Cepheid Investor Relations
Tel: (408) 400 8329
investor.relations@cepheid.com
|
|
|
|
SOURCE Cepheid